Video
- Author:
- Mary Ellen Schneider
Publish date: June 3, 2019
CHICAGO – The Taussig Cancer Institute at the Cleveland Clinic reduced the time to treat for newly diagnosed cancer patients by 33%. Taussig’s chai...
News
- Author:
- Mary Ellen Schneider
Publish date: June 1, 2019
CHICAGO – Researchers examined the use of high- and low-intensity chemotherapy bridging for patients waiting for treatment with a CD19-directed CAR...
News
- Author:
- Mary Ellen Schneider
Publish date: May 24, 2019
The PI3K inhibitor is approved for use with fulvestrant for HR-positive, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer in pati...
News
- Author:
- Mary Ellen Schneider
Publish date: May 16, 2019
The 13-year update to the GITMO-IIL trial showed the important role of complete remission in prolonged survival. This is the longest follow-up ever...
News
- Author:
- Mary Ellen Schneider
Publish date: May 15, 2019
Venetoclax/obinutuzumab was compared with venetoclax/chlorambucil in the CLL14 study and showed superior progression-free survival in previously un...
News
- Author:
- Mary Ellen Schneider
Publish date: March 15, 2019
High-throughput, single telomere–length analysis appears to be a useful tool in predicting response to FCR-based treatment among previously untreat...
News
- Author:
- Mary Ellen Schneider
Publish date: March 8, 2019
Long-term follow-up data from the BRIGHT study support bendamustine plus rituximab as a frontline treatment option in mantle cell lymphoma and indo...
News
- Author:
- Mary Ellen Schneider
Publish date: January 30, 2019
The phase 3b open label trial included extended use of turoctocog alfa among males of all ages with severe hemophilia A.
News
- Author:
- Mary Ellen Schneider
Publish date: January 30, 2019
SAN DIEGO – Thrombin generation appears better able to differentiate between bleeding severities, compared with baseline factor activity.
News
- Author:
- Mary Ellen Schneider
Publish date: January 29, 2019
SAN DIEGO – The Hemophilia Inhibitor PUP Study (HIPS) analyzed Factor VIII–specific antibodies in previously untreated infants with severe hemophil...
News
- Author:
- Mary Ellen Schneider
Publish date: January 29, 2019
News on Dr. Sagar Lonial, Dr. J. Ross Mitchell, Dr. Oren Cahlon, and the death of Dr. Bertrand Coiffier.
News
- Author:
- Mary Ellen Schneider
Publish date: January 17, 2019
Expression of two long noncoding RNAs on the factor VIII gene was lower in patients with severe hemophilia A.
News
- Author:
- Mary Ellen Schneider
Publish date: January 16, 2019
The study examines causes of death for follicular lymphoma patients in the rituximab era.
News
- Author:
- Mary Ellen Schneider
Publish date: January 14, 2019
Movers in Medicine highlights career moves and personal achievements by physicians in the hematology and oncology fields.
News
- Author:
- Mary Ellen Schneider
Publish date: January 9, 2019
The investigational therapy is aimed at preventing vasoocclusive crises.
